Pages
Products
Human HGF adenoviral particles

Human HGF adenoviral particles

Cat.No. :  AD00185Z

Titer: ≥1x10^10 IFU/mL / ≥1x10^11 IFU/mL / ≥1x10^11 VP/mL / ≥1x10^12 VP/mL Size: 100 ul/500 ul/1 mL

Storage:  -80℃ Shipping:  Frozen on dry ice

Inquire for Price

Adenovirus Particle Information

Quality Control

Gene Informationn

Cat. No. AD00185Z
Target Gene HGF
Species Human
Product Type Adenoviral particle
Insert HGF
Titer Varies lot by lot, for example, ≥1x10^10 IFU/mL, ≥1x10^11 IFU/mL, ≥1x10^11 VP/mL etc.
Size Varies lot by lot, for example, 250 ul, 500 ul, 1 mL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Creative Biogene ensures high-quality adenovirus particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between adenovirus particle lots.
Endotoxin Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in adenovirus production, especially for applications in animal studies and gene therapy. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced adenovirus particles to ensure regulatory compliance.
Sterility Creative Biogene ensures that adenovirus products are free of any bacterial, fungal and other microbial contamination.
Ad5 E1 Detection All Creative Biogene adenoviruses are PCR tested to ensure that there are no detectable E1 sequences in the particles, which could be from revertants or external E1 contamination.
RCA Assays Adenovirus products originating at Creative Biogene are guaranteed to have undetectable replication-competent adenovirus (RCA). This quality control measure is important because there is always the possibility of wild-type contamination due to revertants or environmental sources.
PFU Titering All purified adenovirus preparations are tested for infectious titer. Creative Biogene's PFU test takes a few days longer but counts true plaques in HEK cells rather than estimating PFU titers via IHC staining or TCI50 of infected cells.
Gene Name
Gene Symbol
Synonyms
Gene Description
Gene ID
UniProt ID
mRNA Refseq
Protein Refseq
Chromosome Location
Function
Pathway
MIM
Quick Inquiry

Background

Case Study

Publications

Q & A

Customer Reviews

The hepatocyte growth factor (HGF) gene encodes a multifunctional cytokine that plays a key role in tissue regeneration, cell proliferation, and morphogenesis. HGF, also known as scattering factor (SF), is primarily produced by mesenchymal cells and acts on epithelial and endothelial cells through its receptor c-Met. The HGF/c-Met signaling pathway is essential for embryonic development, wound healing, and organ repair, especially in the liver, kidney, and lung. HGF has potent mitogenic, pro-motility, and morphogenic properties, making it a promising target for the treatment of diseases such as liver fibrosis, cardiovascular disease, and tissue damage.

Human HGF adenovirus particles are genetically engineered viral vectors designed to efficiently deliver the HGF gene to target cells. Adenoviruses are a preferred choice for gene transfer due to their high transduction efficiency, broad tropism, and ability to infect both dividing and non-dividing cells. These particles are replication-defective, which prevents uncontrolled viral replication in host tissues, thereby ensuring safety. The recombinant adenovirus carries the human HGF gene and is regulated by a strong promoter, which enables sustained expression of functional HGF protein after infection. Researchers are using these particles in preclinical and clinical studies to explore their therapeutic potential in conditions such as chronic liver damage, myocardial infarction and peripheral artery disease.

The discovery of c-kit+ cardiac stem cells (CSCs) provides us with a new therapeutic target to repair the damaged heart. Necroptosis is a regulated cell death that has recently been shown to occur after myocardial infarction (MI). Here, researchers investigated the effects of hepatocyte growth factor (HGF) and necroptosis on the proliferation and differentiation of endogenous c-kit+ CSCs in the heart after MI in aged rats. HGF/p-Met expression levels and c-kit+ CSC abundance gradually decreased with age. Adenovirus carrying the HGF gene (Ad-HGF) promoted the differentiation of c-kit+ CSCs into precursors of cardiomyocyte, endothelial, and smooth muscle cell lineages and enhanced cardiomyocyte proliferation and angiogenesis in aged rats. These effects were reversed by inhibiting necroptosis. Ad-HGF administration induced necroptosis by increasing the expression of receptor interacting protein kinase (RIP) 1 and receptor interacting protein kinase (RIP) 3 proteins in infarcted hearts. Furthermore, Ad-HGF-induced necroptosis increased high mobility group box 1 (HMGB1) levels and increased the abundance of c-kit+ cells in the bone marrow, which may partly explain the beneficial effects of necroptosis on c-kit+ CSCs. These findings may help develop new approaches to treat ischemic heart disease in the elderly.

HMGB1 is a DNA-binding protein that is secreted by inflammatory and necrotic cells to the extracellular space and functions as a cytokine. It has been reported that exogenous HMGB1 treatment can induce myocardial regeneration after infarction by enhancing the proliferation and differentiation of cardiac c-kit+ cells. Here, the researchers evaluated the level of HMGB1 protein after Ad-HGF treatment. Compared with the Ad-null treatment group, the expression of HMGB1 in the Ad-HGF treatment group was significantly increased, and Nec-1 effectively inhibited this increase (Figure 1A, B). The serum HMGB1 levels before surgery were similar in the two groups, but the serum HMGB1 levels in the Ad-HGF treatment group were significantly increased, and this change could be effectively reversed by inhibiting necroptosis (Figure 1C). Immunofluorescence staining of bone marrow smears showed that inhibition of necroptosis significantly reduced the number of c-kit+ cells in this tissue induced by Ad-HGF treatment (Figure 1D).

Necroptosis induced by Ad-HGF increased the HMGB1 levels and enhanced the c-kit+ cell number in the bone marrow.Figure 1. Necroptosis induced by Ad-HGF increased the HMGB1 levels and enhanced the c-kit+ cell number in the bone marrow. (Liu J, et al., 2016)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Great product!

The HGF adenoviral particles showed strong expression and bioactivity in my wound healing assays. The viral prep was clean, and the results were highly reproducible. Great product!

Germany

02/15/2020

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction

CBpromise

Our promise to you:
Guaranteed product quality, expert customer support.

24x7 CUSTOMER SERVICE
CONTACT US TO ORDER